Depto. Parasitologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Av. Antônio Carlos 6627, Belo Horizonte, MG, Brazil.
Diagn Microbiol Infect Dis. 2013 Feb;75(2):160-4. doi: 10.1016/j.diagmicrobio.2012.11.001.
The chemotherapeutic agents used for the treatment of giardiasis are often associated with adverse side effects and are refractory cases, due to the development of resistant parasites. Therefore the search for new drugs is required. We have previously reported the giardicidal effects of metronidazole (MTZ) and its analogues (MTZ-Ms, MTZ-Br, MTZ-N(3), and MTZ-I) on the trophozoites of Giardia lamblia. Now we evaluated the activity of some giardicidal MTZ analogues in experimental infections in gerbils and its effects on the morphology and ultrastructural organization of Giardia. The giardicidal activity in experimental infections showed ED(50) values significantly lower for MTZ-I and MTZ-Br when compared to MTZ. Transmission electron microscopy was employed to approach the mechanism(s) of action of MTZ analogues upon the protozoan. MTZ analogues were more active than MTZ in changing significantly the morphology and ultrastructure of the parasite. The analogues affected parasite cell vesicle trafficking, autophagy, and triggered differentiation into cysts. These results coupled with the excellent giardicidal activity and lower toxicity demonstrate that these nitroimidazole derivates may be important therapeutic alternatives for combating giardiasis. In addition, our results suggest a therapeutic advantage in obtaining synthetic metronidazole analogues for screening of activities against other infectious agents.
用于治疗贾第虫病的化疗药物通常与不良反应有关,并且由于寄生虫产生耐药性,导致难治病例增加。因此,需要寻找新的药物。我们之前已经报道了甲硝唑(MTZ)及其类似物(MTZ-Ms、MTZ-Br、MTZ-N(3)和 MTZ-I)对蓝氏贾第鞭毛虫滋养体的杀贾第虫作用。现在,我们评估了一些杀贾第虫 MTZ 类似物在实验性感染中的活性及其对贾第虫形态和超微结构组织的影响。实验性感染中的杀贾第虫活性表明,与 MTZ 相比,MTZ-I 和 MTZ-Br 的 ED(50)值显著降低。透射电子显微镜被用来研究 MTZ 类似物对原生动物的作用机制。MTZ 类似物在显著改变寄生虫的形态和超微结构方面比 MTZ 更具活性。这些类似物影响寄生虫细胞囊泡运输、自噬,并引发向囊泡分化。这些结果加上出色的杀贾第虫活性和较低的毒性表明,这些硝基咪唑衍生物可能是治疗贾第虫病的重要替代药物。此外,我们的结果表明,获得用于筛选针对其他感染性病原体的活性的合成甲硝唑类似物具有治疗优势。